| GO:0001501 |
P |
skeletal system development |
| GO:0002158 |
P |
osteoclast proliferation |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0005886 |
C |
plasma membrane |
| GO:0005887 |
C |
integral component of plasma membrane |
| GO:0007189 |
P |
adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0007193 |
P |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO:0007194 |
P |
negative regulation of adenylate cyclase activity |
| GO:0007200 |
P |
phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0008217 |
P |
regulation of blood pressure |
| GO:0008528 |
F |
G protein-coupled peptide receptor activity |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019933 |
P |
cAMP-mediated signaling |
| GO:0030157 |
P |
pancreatic juice secretion |
| GO:0033688 |
P |
regulation of osteoblast proliferation |
| GO:0035810 |
P |
positive regulation of urine volume |
| GO:0042562 |
F |
hormone binding |
| GO:0042803 |
F |
protein homodimerization activity |
| GO:0048015 |
P |
phosphatidylinositol-mediated signaling |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0051000 |
P |
positive regulation of nitric-oxide synthase activity |
| GO:0070062 |
C |
extracellular exosome |